Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004).
about
Management of glucocorticoid-induced osteoporosis: clinical data in relation to disease demographics, bone mineral density and fracture risk.Effects of Denosumab on Bone Metabolic Markers and Bone Mineral Density in Patients Treated with GlucocorticoidsA practical guide to the monitoring and management of the complications of systemic corticosteroid therapyThe Efficacy of Mizoribine (Inosine Monophosphate Dehydrogenase Inhibitor) for ANCA-Associated Vasculitis with Hepatitis B Virus CarrierMultiple pelvic insufficiency fractures in rheumatoid patients with mutilating changes.Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment.The pitfalls in surgical management of lumbar canal stenosis associated with rheumatoid arthritisGlucocorticoid-induced osteoporosis: treatment update and review.Changes of serum soluble receptor activator for nuclear factor-κB ligand after glucocorticoid therapy reflect regulation of its expression by osteoblastsCurcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway.Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates.Comparison of the effect of vitamin K(2) and risedronate on trabecular bone in glucocorticoid-treated rats: a bone histomorphometry studyVery high frequency of fragility fractures associated with high-dose glucocorticoids in postmenopausal women: A retrospective study.Characteristics of lumbar scoliosis in patients with rheumatoid arthritis.A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis.Diagnostic criteria for primary osteoporosis: year 2012 revision.Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis.Clinically applicable antianginal agents suppress osteoblastic transformation of myogenic cells and heterotopic ossifications in mice.Effect of intermittent systemic corticosteroid on bone metabolism in bronchial asthma patients.Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder.Multidetector-row computed tomography is useful to evaluate the therapeutic effects of bisphosphonates in glucocorticoid-induced osteoporosis.Risk factors for bone loss in patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs.Assessment of the effects of switching oral bisphosphonates to denosumab or daily teriparatide in patients with rheumatoid arthritis.Analysis of bone metabolism during early stage and clinical benefits of early intervention with alendronate in patients with systemic rheumatic diseases treated with high-dose glucocorticoid: Early DIagnosis and Treatment of OsteopoRosis in Japan (EGlucocorticoid therapy causes contradictory changes of serum Wnt signaling-related molecules in systemic autoimmune diseases.The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis.Impact of cumulative exposure to high-dose oral glucocorticoids on fracture risk in Denmark: a population-based case-control study.Efficacy of Denosumab for Osteoporosis in Two Patients with Adult-Onset Still's Disease-Denosumab Efficacy in Osteoporotic Still's Disease Patients.The effects of denosumab and alendronate on glucocorticoid-induced osteoporosis in patients with glomerular disease: A randomized, controlled trial.An appendix to the 2012 IOF–ECTS guidelines for the management of glucocorticoid-induced osteoporosisDietary Natural -Acetyl-d-Glucosamine Prevents Bone Loss in Ovariectomized Rat Model of Postmenopausal Osteoporosis
P2860
Q30946308-8BAA429F-B2CC-4B58-AC39-D982EBBD52AAQ33619181-2663EC00-3F6E-4D10-B998-5AF976B1C9FCQ34364143-C50C4F1E-5FBF-44D2-9299-B24460307254Q34393675-01FBD216-E1BD-4307-9CC4-EEA793223009Q35128935-5CB0AACD-626E-4234-B22C-2CE9324CD16AQ35601856-2BCA0A04-6804-45ED-BBC9-D17525914560Q35869526-9D31F2D6-1571-4D21-B074-95D3E87865F3Q36059394-D43E3D6D-FD02-478D-9595-DDAA1AFC19DEQ36293557-8B434CCE-85F5-4240-88F2-781A694FE07DQ36473722-62F3716A-C330-4D3F-B13E-AA6C301EA5BCQ37083734-31693388-AFB5-4F2B-8D8D-60F33A34C9EAQ37183254-CA44FE67-986D-4CF7-BC20-84F55E018150Q37720586-60612B23-CE27-4990-B884-54EF08E5539CQ37729784-AB231454-DA71-45AF-9FED-355CAF825517Q37995500-15B09F25-8FF8-42B1-A97C-94A6F47CF823Q38095829-40FC5F85-FB6D-4C97-B1A8-49295648DE37Q38676353-500AE564-65E1-4E2A-A0E4-2E038AFBDE18Q38702184-19857B93-A5F2-45BD-A4F8-EA5397564A1AQ39271486-F9497E6B-3499-4764-BC6B-CB0C64E6541FQ39875991-7BC7CDF0-62D7-484E-BBB1-2BA6531320EDQ43427754-9682E4FF-6FEA-45F1-8FD2-1306D49B0B4FQ44257423-4D0BD9E3-813C-481C-AA64-36D5A8E44CA0Q47110800-C80CB2C4-26CA-4CCF-AC94-0FD53BA41D7CQ47679545-25D99F4A-5FA6-4850-BC4F-698F8A657DE3Q47962962-2FC05633-8419-452A-93DA-DABF059C3C97Q50975008-F73342E7-53B1-4225-8D4B-2834DFC53A12Q52613909-E7D0C474-3F0D-4A27-81F3-FFDBA8C1008DQ54982067-54F1D911-6B02-4B9C-9804-1FCC368FAAB3Q55004462-B33E92B2-9EE0-455A-B17E-3F090751F51BQ55361679-7EC6AA96-B0F3-4A33-BAEF-C9F3099F46B4Q57417002-9B7C930D-FE16-4835-88EF-00ECCC633CA5Q58696560-1CFF5871-FEAF-47AF-8CFF-F693DA698173
P2860
Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004).
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Guidelines on the management a ...... e and Mineral Research (2004).
@ast
Guidelines on the management a ...... e and Mineral Research (2004).
@en
Guidelines on the management a ...... for Bone and Mineral Research
@nl
type
label
Guidelines on the management a ...... e and Mineral Research (2004).
@ast
Guidelines on the management a ...... e and Mineral Research (2004).
@en
Guidelines on the management a ...... for Bone and Mineral Research
@nl
prefLabel
Guidelines on the management a ...... e and Mineral Research (2004).
@ast
Guidelines on the management a ...... e and Mineral Research (2004).
@en
Guidelines on the management a ...... for Bone and Mineral Research
@nl
P2093
P1476
Guidelines on the management a ...... e and Mineral Research (2004).
@en
P2093
Akira Sagawa
Hajime Nawata
Hiroyuki Tanaka
Ikuko Tanaka
Kunio Takaoka
Masao Fukunaga
Ryoichi Takayanagi
Saeko Fujiwara
Satoshi Soen
Subcommittee to Study Diagnostic Criteria for Glucocorticoid-Induced Osteoporosis
P2888
P304
P356
10.1007/S00774-004-0596-X
P577
2005-01-01T00:00:00Z